Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chan

Showing results (1-10 of 352) with videos related to

Pageof 36
Sort By:
Biologics : Targets & Therapy|November 3, 2025
Antibody-Based Therapeutics for HypercholesterolemiaBrian Tomlinson, Paul Chan
Expert Opinion on Drug Metabolism & Toxicology|April 10, 2024
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an updateBrian Tomlinson, Paul Chan
Expert Opinion on Pharmacotherapy|January 10, 2025
Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemiaBrian Tomlinson, Paul Chan
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2011
23-gauge pars plana vitrectomy for management of posteriorly dislocated crystalline lensMinhee Cho, Rv Paul Chan
Drugs & Aging|March 16, 2006
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertensionG Neil Thomas, Paul Chan, Brian Tomlinson
Seminars in Ophthalmology|December 20, 2005
Treatment options for metastatic tumors to the choroidR V Paul Chan, Lucy H Young
Journal of Pediatric Ophthalmology and Strabismus|March 24, 2015
Intravitreal anti-VEGF therapy as a treatment for retinopathy of prematurity: what we know after 7 yearsMichael A Klufas, R V Paul Chan
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|April 9, 2002
Spasm of accommodation associated with closed head traumaR V Paul Chan, Jonathan D Trobe
Acta Pharmacologica Sinica|December 6, 2002
Protective effects of trilinolein extracted from panax notoginseng against cardiovascular diseasePaul Chan, G Neil Thomas, Brian Tomlinson
Expert Opinion on Pharmacotherapy|October 27, 2022
Evaluating gliclazide for the treatment of type 2 diabetes mellitusBrian Tomlinson, Yan-Hong Li, Paul Chan
Pageof 36

Showing results (1-10 of 352) with videos related to

Sort By:
Pageof 36
Biologics : Targets & Therapy|November 3, 2025
Antibody-Based Therapeutics for HypercholesterolemiaBrian Tomlinson, Paul Chan
Expert Opinion on Drug Metabolism & Toxicology|April 10, 2024
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an updateBrian Tomlinson, Paul Chan
Expert Opinion on Pharmacotherapy|January 10, 2025
Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemiaBrian Tomlinson, Paul Chan
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2011
23-gauge pars plana vitrectomy for management of posteriorly dislocated crystalline lensMinhee Cho, Rv Paul Chan
Drugs & Aging|March 16, 2006
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertensionG Neil Thomas, Paul Chan, Brian Tomlinson
Seminars in Ophthalmology|December 20, 2005
Treatment options for metastatic tumors to the choroidR V Paul Chan, Lucy H Young
Journal of Pediatric Ophthalmology and Strabismus|March 24, 2015
Intravitreal anti-VEGF therapy as a treatment for retinopathy of prematurity: what we know after 7 yearsMichael A Klufas, R V Paul Chan
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|April 9, 2002
Spasm of accommodation associated with closed head traumaR V Paul Chan, Jonathan D Trobe
Acta Pharmacologica Sinica|December 6, 2002
Protective effects of trilinolein extracted from panax notoginseng against cardiovascular diseasePaul Chan, G Neil Thomas, Brian Tomlinson
Expert Opinion on Pharmacotherapy|October 27, 2022
Evaluating gliclazide for the treatment of type 2 diabetes mellitusBrian Tomlinson, Yan-Hong Li, Paul Chan
Pageof 36